Heartsciences vs Phaos Technology Holdings (cayman)
Phaos Technology Holdings (cayman) is the larger business, with $102,806 of revenue in fiscal 2026 against $4,319 for Heartsciences (23.8 times as much). Heartsciences grew faster (-0.7% against -18.2%). Phaos Technology Holdings (cayman) kept more of each dollar of sales as profit: a net margin of -4662.3% against -211666.5%.
| Latest fiscal year | HeartsciencesHSCS, 2026 | Phaos Technology Holdings (cayman)POAS, 2026 |
|---|---|---|
| Revenue | $4,319 | $102,806 |
| Revenue growth | -0.7% | -18.2% |
| Net income | −$9.1m | −$4.8m |
| Operating margin | -194787.4% | — |
| Net margin | -211666.5% | -4662.3% |
| Return on equity | — | — |
| Free cash flow | −$7.4m | −$8.5m |
| Cash | $1.7m | $598,394 |
| Total debt | $3.6m | $61,521 |
| Debt to equity | 1602.3% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 14 | — |
| Market value | $11.6m | $13.5m |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 0 sales |